Survivorship and complications of treatment in breast cancer

Ewa Mrozek; Charles L. Shapiro

Survivorship and complications of treatment in breast cancer

Ewa Mrozek
, Charles L. Shapiro

Research output: Contribution to journal › Review article › peer-review

16 Scopus citations

Abstract

The majority of women treated today for breast cancer are long-term survivors. The overall benefits of adjuvant therapy in women with breast cancer favor treatment even in the subset of patients with node-negative invasive breast cancer. The short- and long-term side effects of combined modality treatment have a significant impact on morbidity and quality of life. Continued emphasis on improving survival, decreasing recurrence, and minimizing treatment toxicity are the goals of ongoing breast cancer research.

Original language	English
Pages (from-to)	211-222+238
Journal	Clinical Advances in Hematology and Oncology
Volume	3
Issue number	3
State	Published - Mar 2005
Externally published	Yes

Keywords

Adjuvant chemotherapy
Breast cancer
Hormonal therapy
Short- and long-term side effects
Survivorship

Cite this

@article{8945664462784e1eac3e3878ebc84579,

title = "Survivorship and complications of treatment in breast cancer",

abstract = "The majority of women treated today for breast cancer are long-term survivors. The overall benefits of adjuvant therapy in women with breast cancer favor treatment even in the subset of patients with node-negative invasive breast cancer. The short- and long-term side effects of combined modality treatment have a significant impact on morbidity and quality of life. Continued emphasis on improving survival, decreasing recurrence, and minimizing treatment toxicity are the goals of ongoing breast cancer research.",

keywords = "Adjuvant chemotherapy, Breast cancer, Hormonal therapy, Short- and long-term side effects, Survivorship",

author = "Ewa Mrozek and Shapiro, \{Charles L.\}",

year = "2005",

month = mar,

language = "English",

volume = "3",

pages = "211--222+238",

journal = "Clinical Advances in Hematology and Oncology",

issn = "1543-0790",

publisher = "Millennium Medical Publishing, Inc.",

number = "3",

}

TY - JOUR

T1 - Survivorship and complications of treatment in breast cancer

AU - Mrozek, Ewa

AU - Shapiro, Charles L.

PY - 2005/3

Y1 - 2005/3

N2 - The majority of women treated today for breast cancer are long-term survivors. The overall benefits of adjuvant therapy in women with breast cancer favor treatment even in the subset of patients with node-negative invasive breast cancer. The short- and long-term side effects of combined modality treatment have a significant impact on morbidity and quality of life. Continued emphasis on improving survival, decreasing recurrence, and minimizing treatment toxicity are the goals of ongoing breast cancer research.

AB - The majority of women treated today for breast cancer are long-term survivors. The overall benefits of adjuvant therapy in women with breast cancer favor treatment even in the subset of patients with node-negative invasive breast cancer. The short- and long-term side effects of combined modality treatment have a significant impact on morbidity and quality of life. Continued emphasis on improving survival, decreasing recurrence, and minimizing treatment toxicity are the goals of ongoing breast cancer research.

KW - Adjuvant chemotherapy

KW - Breast cancer

KW - Hormonal therapy

KW - Short- and long-term side effects

KW - Survivorship

UR - https://www.scopus.com/pages/publications/25844508926

M3 - Review article

C2 - 16166992

AN - SCOPUS:25844508926

SN - 1543-0790

VL - 3

SP - 211-222+238

JO - Clinical Advances in Hematology and Oncology

JF - Clinical Advances in Hematology and Oncology

IS - 3

ER -

Survivorship and complications of treatment in breast cancer

Abstract

Keywords

Fingerprint

Cite this